GRASSI GUIDO

Cuspidi, C., Facchetti, R., Quarti-Trevano, F., Dell'Oro, R., Mancia, G., Grassi, G. (2024). Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study. AMERICAN JOURNAL OF HYPERTENSION [10.1093/ajh/hpae022]. Detail

Quarti Trevano, F., Bernal, S., Facchetti, R., Cuspidi, C., Mancia, G., Grassi, G. (2024). Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study. JOURNAL OF HYPERTENSION [10.1097/HJH.0000000000003709]. Detail

D’Elia, L., Masulli, M., Cirillo, P., Virdis, A., Casiglia, E., Tikhonoff, V., et al. (2024). Serum Uric Acid/Serum Creatinine Ratio and Cardiovascular Mortality in Diabetic Individuals—The Uric Acid Right for Heart Health (URRAH) Project. METABOLITES, 14(3) [10.3390/metabo14030164]. Detail

Faggiano, A., Gherbesi, E., Tadic, M., Carugo, S., Grassi, G., Cuspidi, C. (2024). Do We Need New Electrocardiographic Criteria for Left Ventricular Hypertrophy? The Case of the Peguero–Lo Presti Criterion. A Narrative Review. AMERICAN JOURNAL OF HYPERTENSION, 37(3 (March 2024)), 155-162 [10.1093/ajh/hpad117]. Detail

Mancia, G., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M., et al. (2024). Rationale of treatment recommendations in the 2023 ESH hypertension guidelines. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 121(March 2024), 4-8 [10.1016/j.ejim.2023.12.015]. Detail